WarkanyJ. Congenital malformations in the past. J Chronic Dis1959; 10: 84–96.
2.
ShepardTH. Catalog of teratogenic agents. 2nd ed.Baltimore: Johns Hopkins University Press, 1976: 1–246.
3.
MillerRR. Prescribing habits of physicians, parts I-VIII. Drug Intell Clin Pharm1973; 7: 492–500, 557–564; 1974; 8: 81–91.
4.
SchardeinJL. Drugs as teratogens. Cleveland: CRC Press, 1976: 1–274.
5.
HarleyJDFarrarJFGrayJBDunlopIC. Aromatic drugs and congenital cataracts. Lancet1964; 1: 472–3.
6.
CharVCChandraRFletcherABAveryGB. Polyhydramnios and neonatal renal failure—a possible association with maternal acetaminophen ingestion. J Pediatr1975; 86: 638–9.
7.
LubawyWCGarrettRJB. Effects of aspirin and acetaminophen on fetal and placental growth in rats. J Pharm Sci1977; 66: 111–3.
8.
SpeidelBDMeadowSR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet1972; 2: 839–43.
9.
McBrideWG. The teratogenic action of drugs. Med J Aust1963; 2: 689–93.
10.
Tuchman-DuplessisH. Drug effects on the fetus. Acton: Publishing Sciences Group, 1975: 1–267.
11.
MalinsJMCookeAMPykeDAFitzgeraldMG. Sulphonylurea drugs in pregnancy. Br Med J1964; 2: 187.
12.
ButrosJ. Action of some cardiovascular and neurohumoral agents on the formulation of the chick embryo heart. Teratology1972; 6: 167–75.
13.
JonesKLSmithDWUllelandCNStreissguthAP. Pattern of malformation of offspring of chronic alcoholic mothers. Lancet1973; 1: 1267–71.
14.
ClarrenSKSmithDW. The fetal alcohol syndrome. N Engl J Med1978; 298: 1063–7.
15.
LowryRB. The Klippel-Feil anomalad as part of the fetal alcohol syndrome. Teratology1977; 16: 53–6.
16.
StreissguthAP. Psychologic handicaps in children with the fetal alcohol syndrome. Ann NY Acad Sci1976; 273: 140–5.
17.
JonesKLSmithDWHansonJW. The fetal alcohol syndrome: Clinical delineation. Ann NY Acad Sci1976; 273: 130–7.
18.
De BeukelaerMMRandallCStroudDR. Renal anomalies in the fetal alcohol syndrome. J Pediatr1977; 91: 759–60.
19.
StreissguthAPHermannCSSmithDW. Intelligence, behavior, and dysmorphogenesis in the fetal alcohol syndrome: A report on 20 patients. J Pediatr1978; 92: 363–7.
20.
HansonJWStreissguthAPSmithDW. The effects of moderate alcohol consumption during pregnancy on fetal growth and morphogenesis. J Pediatr1978; 92: 457–60.
21.
JonesKLSmithDW. Recognition of the fetal alcohol syndrome in early infancy. Lancet1973; 2: 999–1001.
PierogSChandavasuOWexlerI. Withdrawal symptoms in infants with the fetal alcohol syndrome. J Pediatr1977; 90: 630–3.
24.
BadrFMBadrRS. Induction of dominant lethal mutations in male mice by ethyl alcohol. Nature1975; 253: 134–6.
25.
WileyMJJonejaMG. The teratogenic effects of β-aminopropionitrile in hamsters. Teratology1976; 14: 43–52.
26.
WarkanyJ. Aminopterin and methotrexate: Folic acid deficiency. Teratology1978; 17: 353–8.
27.
GellisSSFeingoldM. Aminopterin embropathy syndrome. Am J Dis Child1979; 133: 1189–90.
28.
KheraKS. Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Teratology1976; 14: 21–8.
29.
LoweCR. Congenital defects among children born to women under supervision or treatment for pulmonary tuberculosis. Br J Prev Soc Med1964; 18: 14–16.
30.
MarcusJC. Non-teratogenicity of antituberculous drugs. S Afr Med J1967; 41: 758–9.
31.
JacobsD. Imipramine (Tofranil®). S Afr Med J1972; 46: 1023.
32.
RachelefskyGS. Possible teratogenicity of tricyclic antidepressants. Lancet1972; 1: 838.
33.
BanisterP. Possible teratogenicity of tricyclic antidepressants. Lancet1972; 1: 838–9.
34.
SimM. Imipramine and pregnancy. Br Med J1972; 2: 45.
35.
KuenssbergEVKnoxJDE. Imipramine in pregnancy. Br Med J1972; 2: 292.
36.
FreemanR. Limb deformities: Possible association with drugs. Med J Aust1972; 1: 606–7.
37.
MilkovichLVan Den BergBJ. Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol1977; 129: 637–42.
38.
ErikssonMLarssonGWinbladhBZetterströmR. The influence of amphetamine addiction on pregnancy and the newborn infant. Acta Paediatr Scand1978; 67: 95–9.
39.
BiggsGGSamsonJHCrawfordDJ. Lack of abnormalities in a newborn infant exposed to amphetamine during gestation. Am J Dis Child1975; 129: 249–50.
40.
CohenENBellvilleJWBrownBW. Anesthesia, pregnancy, and miscarriage: A study of operating room nurses and anesthetists. Anesthesiology1971; 35: 343–7.
41.
Committee on the Effects of Trace Anesthetics on the Health of Operating Room Personnel.Occupational disease among operating room personnel: A national study. Anesthesiology1974; 41: 321–40.
42.
TomlinPJ. Teratogenic effects of waste anaesthetic gases. Br Med J1978; 1: 108.
43.
CorbettTHCornellRGEndusJLLiedingK. Birth defects among children of nurse-anesthetists. Anesthesiology1974; 41: 341–4.
44.
LugoGCassadyGPalmisanoP. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child1969; 117: 328–30.
45.
MerkatzIRSchwartzGHDavidDSStenzelKHRiggioRRWhitsellJC. Resumption of female reproductive function following renal transplantation. JAMA1971; 216: 1749–54.
46.
PriceHVSolomanJRLaurenceKMLangmaidH. Immunosuppressive drugs and the foetus. Transplant1976; 21: 294–8.
47.
ScottJR. Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am J Obstet Gynecol1977; 128: 668–76.
48.
MilkovichLVan Den BergBJ. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol1976; 125: 244–8.
49.
SmithellsRWSheppardS. Teratogenicity testing in humans: A method demonstrating safety of Bendectin®. Teratology1978; 17: 31–6.
50.
LeatherHMHumphreysDMBakerPChaddMA. A controlled trial of hypotensive agents in hypertension in pregnancy. Lancet1968; 2: 488–90.
51.
OpitzJMGrosseFRHanebergB. Congenital effects of bromism. Lancet1972; 1: 91–2.
52.
GreenbergerPPattersonR. Safety of therapy for allergic symptoms during pregnancy. Ann Intern Med1978; 89: 234–7.
53.
KingCTGHowellJ. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol1966; 95: 109–11.
54.
BorosSJReynoldsJW. Intrauterine growth retardation following third-trimester exposure to busulfan. Am J Obstet Gynecol1977; 129: 111–2.
55.
HodgkinsonRHuffRWHagashiRHHusainF. Double-blind comparison of maternal analgesia and neonatal neurobehaviour following intravenous butorphanol and meperidine. J Int Med Res1979; 7: 224–30.
56.
WeathersbeePSOlsenLKLodgeJR. Caffeine and pregnancy. Postgrad Med1977; 62 (3): 64–9.
57.
WeathersbeePSAxRLLodgeJR. Caffeine mediated changes of sex ratio in Chinese hamsters Cricetulus Griseus. J Reprod Fertil1975; 43: 141–3.
58.
YieldingLWRileyTLYieldingKL. Preliminary study of caffeine and chloroquine enhancement of X-ray induced birth defects. Biochem Biophys Res Comm1976; 68: 1356–61.
59.
PalmPEArnoldEPRachwallPCLeyczekJCTeagueKWKenslerCJ. Evaluation of the teratogenic potential of fresh-brewed coffee and caffeine in the rat. Toxicol Appl Pharmacol1978; 44: 1–16.
60.
SoykaLF. Effect of methylxanthines on the fetus. Clin Perinatol1979; 6: 37–51.
61.
Starreveld-ZimmermanAAEVan Der KolkWJMeinardiA. Are anticonvulsants teratogenic?Lancet1973; 2: 48–9.
62.
MillarJHDNevinNC. Congenital malformations and anticonvulsant drugs. Lancet1973; 1: 328.
63.
IbbertsonHKSeddonRJCroxsonMS. Fetal hypothyroidism complicating medical treatment of thyrotoxicosis in pregnancy. Clin Endocrinol1975; 4: 521–3.
64.
SaxenI. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol1975; 4: 11–44.
65.
HartzSCHeinonenCPShapiroSSiskindVSloneD. Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N Engl J Med1975; 292: 726–8.
66.
CrombieDLPinsentRJFlemingDMRumeau-RouquetteCGoujardJHuelG. Fetal effects of tranquilizers in pregnancy. N Engl J Med1975; 293: 198–9.
67.
SaxenISaxenL. Association between maternal intake of diazepam and oral clefts. Lancet1975; 2: 498.
68.
MilkovichLVan Den BergBJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med1974; 291: 1268–71.
69.
KlumppTG. Safety of chloroquine in pregnancy. JAMA1965; 191: 765.
Rumeau-RouquetteCGoujardJHuelG. Possible teratogenic effect of phenothiazines in human beings. Teratology1977; 15: 57–64.
76.
ZellersJEGautieriRF. Evaluation of teratogenic potential of codeine sulfate in CF-1 mice. J Pharm Sci1977; 66: 1727–30.
77.
HoffeldDRWebsterRLMcNewJ. Adverse effects on offspring of tranquilizing drugs during pregnancy. Nature1967; 215: 182–3.
78.
SherryCJ. Chlorpromazine: A potential physiological teratogen. Experientia1977; 33: 493–4.
79.
SutherlandHWStowersJMCormackJDBewsherPD. Evaluation of chlorpropamide in chemical diabetes diagnosed during pregnancy. Br Med J1973; 3: 9–13.
80.
SutherlandHWBewsherPDCormackJD, Effect of moderate dosage of chlorpropamide in pregnancy on fetal outcome. Arch Dis Child1974; 49: 283–91.
81.
DouglasCPRichardsR. Use of chlorpropamide in the treatment of diabetes in pregnancy. Diabetes1967; 16: 60–1.
82.
NotelovitzM. Sulphonylurea therapy in the treatment of the pregnant diabetic. S Afr Med J1975; 45: 226–9.
83.
CampbellGD. Chlorpropamide and foetal damage. Br Med J1963; 1: 59–60.
84.
JacksonWPU. Chlorpropamide in diabetic pregnancy. Lancet1974; 2: 843.
85.
JacksonWPUCampbellGDNotelovitzMBlumsohnD. Tolbutamide and chlorpropamide during pregnancy in human diabetics. Diabetes1962; 11(Suppl): 98–103.
86.
WeseleyACDouglasGK. Continuous use of chlorothiazide for prevention of toxemia of pregnancy. Obstet Gynecol1962; 19: 355–8.
87.
SinghMSinghiS. Possible relationship between clomiphene and neural tube defects. J Pediatr1978; 93: 152.
88.
PopertAJ. Pregnancy and adrenocortical hormones. Some aspects of their interaction in rheumatic diseases. Br Med J1962; 1: 967–72.
89.
WellsCN. Treatment of hyperemesis gravidarum with cortisone. Am J Obstet Gynecol1953; 66: 598–601.
90.
DoigRKColtmanOM. Cleft palate following cortisone therapy in early pregnancy. Lancet1956; 2: 730.
91.
HarrisJWSRossIP. Cortisone therapy in early pregnancy: Relation to cleft palate. Lancet1956; 1: 1045–7.
92.
OrnoyA. Effects of maternal hypercortisonism and hypervitaminosis D2 on fetal osteogenesis ossification in rats. Teratology1971; 4: 383–94.
93.
OrnoyAHorowitzAKaspiTMichaeliYNebelL. Anomalous fetal and neonatal bone development induced by administration of cortisone and vitamin D2 to pregnant rats. Adv Exp Med Biol1972; 27: 219–26.
94.
SadovskyEPfeiferYPolishukWASulmanFG. The use of antiserotonin-cyproheptadine HCl in pregnancy: An experimental and clinical study. Adv Exp Med Biol1972; 27: 399–405.
95.
RitterEJScottWJWilsonJG. Teratogenesis and inhibition of DNA synthesis induced in rat embryos by cytosine arabinoside. Teratology1971; 4: 7–14.
96.
EdelstoneDIMueller-HeubackECaritisSN. Effects of dexamethasone on maternal and fetal hemodynamic states and fetal oxygenation. Am J Obstet Gynecol1977; 127: 273–7.
97.
MilnerRDGChoukseySK. Effects of fetal exposure to diazeoxide in man. Arch Dis Child1972; 47: 537–43.
98.
NuwayhidBBrinkmanCRKatchenBSymchowiczSMartinekHAssaliNS. Maternal and fetal hemodynamic effects of diazoxide. Obstet Gynecol1975; 46: 197–203.
99.
SafraMJOakleyGP. Association between cleft lip with or without cleft palate and pre-natal exposure to diazepam. Lancet1975; 2: 478–9.
100.
AarskogD. Association between maternal intake of diazepam and oral clefts. Lancet1975; 2: 921.
101.
IstvanEJ. Drug associated congenital abnormalities. Can Med Assoc J1970; 103: 1394.
102.
RingroseCA Douglas. The hazards of neurotropic drugs in the fertile years. Can Med Assoc J1972; 106: 1058.
103.
HeinonenOPSloneDMonsonRRHookEBShapiroS. Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med1977; 296: 67–70.
104.
SauroVGiorpeliiCGiornelliFE SantilliFanelliA. Effetti di un ferro-chelante sullo gravidanza della rotta. Indiagini sperimentali. Arch Ostet Ginecol1968; 73: 269–83.
105.
NoraAHNoraJJ. A syndrome of multiple congenital anomalies associated with teratogenic exposure. Arch Environ Health1975; 30: 17–21.
106.
ReinischJM. Prenatal exposure of human foetuses to synthetic progestin and oestrogen affects personality. Nature1977; 266: 561–2.
107.
JohnstonRFHarrisHWKnightRADufourAWallerJB. Multiple retreatment drug regimens for pulmonary tuberculosis. Ann NY Acad Sci1966; 135: 831–4.
108.
LewitTNebelLTerracinaSKarmanS. Ethambutol in pregnancy: Observations on embryogenesis. Chest1974; 66: 25–6.
109.
BobrowitzID. Ethambutol in pregnancy. Chest1974; 66: 20–4.
110.
KullanderSKällenB. A prospective study of drugs and pregnancy. Acta Obstet Gynecol Scand1976; 55: 221–4.
111.
YasudaYKikaraTNishimuraH. Effect of prenatal treatment of ethinyl estradiol on the mouse uterus and ovary. Am J Obstet Gynecol1977; 127: 832–6.
112.
GrumbachMMDucharmeJRMoloshokRE. On the fetal masculinizing action of certain oral progestins. J Clin Endocrinol Metab1959; 19: 1369–80.
113.
HillRMVerniaudWMHorningMGMcCulleyLBMorganNF. Infants exposed in utero to antiepileptic drugs. Am J Dis Child1974; 127: 645–53.
114.
HansonJWOakleyGP. Haloperidol and limb deformities. JAMA1975; 231: 26.
115.
Van VaesAVan DeVeldeE. Safety evaluation of Haloperidol in treatment of hyperemesis gravidarum. J Clin Pharmacol1969; 9: 224–7.
116.
KopelmanAEMcCullarFWHeggenessL. Limb malformations following maternal use of Haloperidol. JAMA1975; 231: 62–4.
117.
PopeWDBHalseyMJLansdownABGBatemanPE. Lack of teratogenic dangers with halothane. Acta Anaesthesiol Belg1975; 26(Suppl): 169–73.
118.
KandallSRAlbinSGartnerLMLeeKSEidelmanALowinsonJ. The narcotic-dependent mother: Fetal and neonatal consequences. Early Hum Dev1977; 1: 159–69.
119.
FinneganLP. In utero opiate dependence and sudden infant death syndrome. Clin Perinatol1979; 6: 163–80.
120.
ClamanADStrangRI. Obstetric and gynecologic aspects of heroin addiction. Am J Obstet Gynecol1962; 83: 252–7.
121.
HarperRGSolishGIPurowHMSangEPane-PintoWC. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Pediatrics1974; 54: 300–5.
122.
StoneMLSalernoLJGreenMZelsonC. Narcotic addiction in pregnancy. Am J Obstet Gynecol1971; 109: 716–23.
123.
ZelsonCRubioEWassermanE. Neonatal narcotic addiction: 10 year observation. Pediatrics1971; 48: 178–89.
124.
ReddyAMHarperRGSternG. Observations on heroin and methadone withdrawal in the newborn. Pediatrics1971; 48: 353–8.
125.
BlinickGJerezEWallachRC. Methadone maintenance, pregnancy, and progeny. JAMA1973; 225: 477–9.
126.
KendallSRAlbinSDreyerEComstockMLowinsonJ. Differential effects of heroin and methadone on birth weights. Addict Dis1975; 2: 347–55.
127.
PembryMEClarkeCAFraisMM. Normal child after maternal thalidomide ingestion in critical period of pregnancy. Lancet1970; 1: 275–7.
128.
KrausGWMarcheseJRYenSSC. Prophylactic use of hydrochlorothiazide in pregnancy. JAMA1966; 198: 1150–4.
129.
FallisNEPlaucheWCMoseyLMLongfordHG. Thiazide versus placebo in prophylaxis of toxemia of pregnancy in primigravid patients. Am J Obstet Gynecol1964; 88: 502–4.
130.
MackayEVKhooSK. Clinical and laboratory study of a new diuretic agent (Vectren®) in pregnancy: A comparison with a diuretic agent in current use (Enduron®). Med J Aust1969; 1: 607–12.
131.
AriasFZamoraJ. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol1979; 53: 489–94.
132.
BrunnerRLMcLeanMVorheesCVButcherRE. A comparison of behavioral and anatomical measures of hydroxyurea induced abnormalities. Teratology1978; 18: 379–84.
133.
SmithDWClarrenSKHarveyMAS. Hyperthermia as a possible teratogenic agent. J Pediatr1978; 92: 878–83.
134.
ItoiMGefterJWKanekoNIshiiYRamerRMGassetAR. Teratogenicity of ophthalmic drugs. I. Antiviral ophthalmic drugs. Arch Ophthalmol1975; 93: 46–51.
135.
MorrowAWPittDBWilkinsGD. Limb deformities associated with iminodibenzyl hydrochloride. Med J Aust1972; 1: 658–9.
136.
BarsonJ. Malformed infant. Br Med J1972; 2: 45.
137.
LevinDLFixlerDEMorrissFCTysonJ. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr1978; 92: 478–83.
138.
CsabaIFSulyokEErtlT. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediatr1978; 92: 484.
139.
RubaltelliFFChiozzaMLZanardoVCantaruttiF. Effect on neonate of maternal treatment with indomethacin. J Pediatr1979; 94: 161.
140.
ThomsonJARileyID. Neonatal thyrotoxicosis associated with maternal hypothyroidism. Lancet1966; 1: 635–6.
141.
SeniorBChernoffHL. Iodide goiter in the newborn. Pediatrics1971; 47: 510–5.
142.
Drug distribution: Passage of drugs across the placenta. In: GoldsteinAAronowLKalmanSM. Principles of drug action: The basis of pharmacology. New York: John Wiley and Sons, 1974: 198–210.
143.
VilleeCA. Placental transfer of drugs. Ann NY Acad Sci1965; 123: 237–44.
144.
AngleCRMcIntireMS. Lead poisoning during pregnancy. Am J Dis Child1964; 108: 436–9.
145.
SinghNDonovanCMHanshawJB. Neonatal lead intoxication in a prenatally exposed infant. J Pediatr1978; 93: 1019–21.
146.
TimpoAEAminJSCasalinoMBYuceogluAM. Congenital lead intoxication. J Pediatr1979; 94: 765–7.
147.
StoweHDGoyerRA. The reproductive ability and progeny of F1 lead toxic rats. Fertil Steril1971; 22: 755–60.
148.
BradyKHerreraYZenickH. Influence of parenteral lead exposure on subsequent learning ability of offspring. Pharmacol Biochem Behav1975; 3: 561–5.
149.
MickalADildyGAMillerHJ. Lincomycin in the treatment of cervicitis and vaginitis in pregnancy. South Med J1966; 59: 567–70.
150.
MickalAPanzerJD. The safety of lincomycin in pregnancy. Am J Obstet Gynecol1975; 121: 1071–4.
151.
KheraKSWhalenCTrivettG. Teratogenicity studies on linuron, malathion, and methoxychlor in rats. Toxicol Appl Pharmacol1978; 45: 435–44.
152.
SchouM. What happens later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiat Scand1976; 54: 193–7.
153.
WeinsteinMRGoldfieldMD. Lithium carbonate treatment during pregnancy. Dis Nerv Svs1969; 30(Suppl): 828–32.
154.
WeinsteinMRGoldfieldMD. Cardiovascular malformations with lithium use during pregnancy. Am J Pschiatry1975; 132: 529–31.
155.
RaneABjarkeB. Effects of maternal lithium therapy in a newborn infant. J Pediatr1978; 93: 296–7.
156.
TunnessenWWHertzCG. Toxic effects of lithium in newborn infants: A commentary. J Pediatr1972; 81: 804–7.
157.
StothersJKWilsonDWRoystonN. Lithium toxicity in the newborn. Br Med J1973; 3: 233–4.
158.
WrightTLHoffmanLHDaviesJ. Teratogenic effects of lithium in rats. Teratology1971; 4: 151–6.
159.
WrightPLSmithSHKeplingerMLCalandraJCBraudeMC. Reproductive and teratologic studies with Δ9-tetrahydrocannabinol and crude marijuana extract. Toxicol Appl Pharmacol1976; 38: 223–35.
160.
BattsJAPunnettHHValdes-DapenaMColesJWGreenWR. A case of cyclopia. Am J Obstet Gynecol1972; 112: 657–61.
161.
BursteinRWassermanHC. The effect of provera on the fetus. Obstet Gynecol1964; 23: 931–4.
162.
HansonJWMyrianthopoulosNCSedgwickMASmithDW. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr1976; 89: 662–8.
StimmelBAdamsonsK. Narcotic dependency in pregnancy. Methadone maintenance compared to use of street drugs. JAMA1976; 235: 1121–4.
165.
NewmanRGBashkowSCalkoD. Results of 313 consecutive live births of infants delivered to patients in the New York City methadone maintenance treatment program. Am J Obstet Gynecol1975; 121: 233–7.
166.
CobrinikRWHoodTChusidE. The effect of maternal narcotic addiction on the newborn infant. Pediatrics1959; 24: 288–304.
167.
GanguinGRemptE. Streptomycin Behandlung in der Schwangerschaft und ihre Auswerkung auf das Gehör Kindes. Z Laryngol Rhinol Otol Grenzgeb1970; 49: 496–503.
168.
BursteinYGiardinaPJVRausenARKandallSRSiljestromKPetersonCM. Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users. J Pediatr1979; 94: 895–9.
169.
SmithDJJoffeJM. Increased neonatal mortality in offspring of male rats treated with methadone or morphine before mating. Nature1975; 253: 202–3.
170.
JoffeJMPetersonJMSmithDJSoykaLF. Sublethal effects on offspring of male rats treated with methadone before mating. Res Commun Chem Pathol Pharmacol1976; 13: 611–21.
171.
SoykaLFPetersonJMJoffeJM. Lethal and sublethal effects on the progeny of male rats treated with methadone. Toxicol Appl Pharmacol1978; 45: 797–807.
MujtabaQBarrowGN. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol1975; 46: 282–6.
174.
RefetoffSOchiYSelenkowHARosenfieldRL. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs. J Pediatr1974; 85: 240–4.
175.
RedmanCWGBeilinLJBonnarJOunstedMK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet1976; 2: 753–6.
176.
Kincaid-SmithPBullenM. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J1966; 1: 274–6.
177.
WarkanyJTakacsE. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol1959; 35: 315–24.